Inspection Record

Front Range Laboratories, Incorporated — FDA 483 Findings

US FDAInspected 2015-07-11Published 2024-01-17 5 findingsContamination controlTraining and personnelLaboratory and QC controlsQuality unit oversight

View the regulator's official source The source document is always the basis for judgement.

Findings

1Contamination control

Protective apparel is not worn as necessary to protect drug products from contamination.

2Training and personnel

Employees engaged in the manufacture, processing, packing, and holding ofa drug product lack the education, training, and experience required to perfotm their assigned functions.

3Laboratory and QC controls

Laboratory controls do not include the establishment of scientifically sound and appropriate specifications, standards, sampling plans, and test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.

4Quality unit oversight

There is no quality control unit.

5Laboratory and QC controls

The written stability program for drug products does not include reliable, meaningful, and specific test methods.

About this record

Extracted automatically from the document US FDA published on 2024-01-17. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Front Range Laboratories, Incorporated company profile — full history US FDA documents, 2024 Go to Findings search